AviClear is the first and original device cleared for the treatment of mild, moderate and severe acne – AviClear is only currently available in North America. For updates on availability in your region, register your interest today.
As a proud innovator and first-to-market brand, Cutera is delighted to have successfully launched AviClear in late 2022 with already 1,000+ practices across North America choosing to adopt this novel 1726 nm laser technology, proven to treat acne at the source by selectively targeting and suppressing the sebaceous gland safely and effectively.
In three 30-minute treatment sessions, 90% of patients experienced a visible improvement in their acne six months after their third session.1 According to 12-month clinical data, improvement increases to 92%2, confirming the long-term efficacy of acne clearance and skin quality over time.
Since its launch, AviClear has made waves in the industry, winning ten major beauty awards from top industry publications, including NewBeauty, Elle, Good Housekeeping and two wins from Cosmopolitan. With the device’s rising popularity, thousands of people across North America have already been treated with AviClear, while Cutera continues to invest in research and new applications.
of patients had a ≥50% reduction in inflammatory lesions at six months after the final treatment session (up from 80% at three months).1§
Moderate and severe acne patients had a reduction of
in mean nodule count at six months after the final treatment session.1
reduction in inflammatory lesion count at two years.2
AviClear is designed with the exclusive AviCool.
The combination of sapphire contact cooling and smart sensors provides a safe and comfortable treatment experience. 2†
Patients have described the sensation of AviClear treatments like a “light snapping against the skin.”
The median score of treatment comfortability was five out of ten.1
AviClear is a significant revenue-generating opportunity for your practice. You pay Cutera as you go so your risk is minimal.
Dr. David Goldberg
Dermatologist
I chose AviClear because I wanted to have a long-term option for patients suffering with acne that did not include the need for an oral medication. My patients are thrilled that their acne is greatly reduced, or even gone all together, and three 30 minute treatments spaced 30 days apart.
Dermatologist
I chose AviClear because it is a revolutionary laser, that for the first time ever targets, the oil glands that cause acne. In my practice, we’ve been seeing great results – it’s a safe and effective option for mild, moderate and severe acne plus has none of the side effects associated with other acne medication.
Dr. Dennis Gross
Dermatologist
AviClear is rolling out to physicians throughout the United States over the course of 2023. Doctors and patients from Europe and outside of North America are encouraged to join the exclusive wait list and sign up for updates on product availability and local treatment providers.
*AviClear is only currently available in North America. For updates on availability in your region, register today.
References: 1. Data on file. FDA clearance study. Cutera, Inc. 2. Data on file. Cutera, Inc. *AviClear is also Health Canada approved for acne scars. †Comfort level varies by tolerance. There were no instances of dropout reported in the clinical trials. ‡For U.S. acne patients opting for isotretinoin treatment only. §Treatment success was defined as a reduction in inflammatory lesions of greater than or equal to 50%.
